Ratings by RBC Capital (Luca Issi)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/22/2024 | Ultragenyx Pharma | RARE | New Coverage | Outperform (N/A) |
43.38 (43.08) |
-0.69% | Details | |
| 3/27/2024 | Korro Bio Inc. | KRRO | Maintain | Outperform (N/A) |
|
Details | ||
| 3/19/2024 | Adverum Biotechnologies | ADVM | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/12/2024 | Lexeo Therapeutics | LXEO | Maintain | Outperform (N/A) |
|
Details | ||
| 3/8/2024 | Regenxbio Inc. | RGNX | Upgrade | Outperform (Sector Perform) |
23.23 (15.75) |
-32.2% | Details | |
| 3/6/2024 | WAVE Life Sciences | WVE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/27/2024 | Beam Therapeutics Inc | BEAM | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/22/2024 | CRISPR Therapeutics | CRSP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 2/12/2024 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 1/26/2024 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 1/22/2024 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 12/11/2023 | CRISPR Therapeutics | CRSP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/29/2023 | Korro Bio Inc. | KRRO | New Coverage | Outperform (N/A) |
39.92 (59.76) |
49.7% | Details | |
| 11/28/2023 | Lexeo Therapeutics | LXEO | New Coverage | Outperform (N/A) |
11.30 (12.47) |
10.35% | Details | |
| 11/10/2023 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2023 | uniQure BV | QURE | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2023 | CRISPR Therapeutics | CRSP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/3/2023 | Moderna | MRNA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2023 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2023 | Sangamo BioSciences | SGMO | Downgrade | Sector Perform (Outperform) |
0.59 (0.46) |
-22.03% | Details | |
| 10/11/2023 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 8/11/2023 | MeiraGTx Holdings plc | MGTX | Maintain | Outperform (N/A) |
|
Details | ||
| 8/9/2023 | Sangamo BioSciences | SGMO | Maintain | Outperform (N/A) |
|
Details | ||
| 8/4/2023 | Moderna | MRNA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/1/2023 | uniQure BV | QURE | Maintain | Outperform (N/A) |
|
Details | ||
| 7/25/2023 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 5/12/2023 | MeiraGTx Holdings plc | MGTX | Maintain | Outperform (N/A) |
|
Details | ||
| 5/11/2023 | Beam Therapeutics Inc | BEAM | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/8/2023 | Editas Medicine | EDIT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/4/2023 | Regenxbio Inc. | RGNX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/15/2023 | MeiraGTx Holdings plc | MGTX | Maintain | Outperform (N/A) |
|
Details | ||
| 3/2/2023 | Moderna | MRNA | New Coverage | Sector Perform (N/A) |
138.81 (107.09) |
-22.85% | Details | |
| 2/9/2023 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 2/7/2023 | Arrowhead Pharma | ARWR | Maintain | Outperform (N/A) |
|
Details | ||
| 1/6/2023 | Graphite Bio Inc | GRPH | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/18/2022 | Editas Medicine | EDIT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/11/2022 | WAVE Life Sciences | WVE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/11/2022 | Homology Medicines | FIXX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/11/2022 | Adverum Biotechnologies | ADVM | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/8/2022 | Verve Therapeutics | VERV | Maintain | Outperform (N/A) |
|
Details | ||
| 11/7/2022 | bluebird bio | BLUE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/7/2022 | Beam Therapeutics Inc | BEAM | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/4/2022 | Regenxbio Inc. | RGNX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/4/2022 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2022 | Editas Medicine | EDIT | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/2/2022 | CRISPR Therapeutics | CRSP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/4/2022 | Regenxbio Inc. | RGNX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 9/20/2022 | Alnylam Pharmaceuticals | ALNY | Maintain | Outperform (N/A) |
|
Details | ||
| 8/12/2022 | Adverum Biotechnologies | ADVM | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/5/2022 | bluebird bio | BLUE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/4/2022 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/4/2022 | Regenxbio Inc. | RGNX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/13/2022 | Caribou Biosciences Inc. | CRBU | Maintain | Outperform (N/A) |
|
Details | ||
| 5/10/2022 | CRISPR Therapeutics | CRSP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 5/3/2022 | Sangamo BioSciences | SGMO | Maintain | Outperform (N/A) |
|
Details | ||
| 5/3/2022 | Sangamo BioSciences | SGMO | Maintain | Outperform (N/A) |
|
Details | ||
| 2/22/2022 | Homology Medicines | FIXX | Downgrade | Sector Perform (Outperform) |
3.86 (0.93) |
-75.91% | Details | |
| 2/18/2022 | Graphite Bio Inc | GRPH | New Coverage | Sector Perform (N/A) |
11.02 (3.18) |
-71.14% | Details | |
| 2/18/2022 | Caribou Biosciences Inc. | CRBU | New Coverage | Outperform (N/A) |
11.37 (3.74) |
-67.11% | Details | |
| 2/18/2022 | Verve Therapeutics | VERV | New Coverage | Outperform (N/A) |
30.21 (6.21) |
-79.44% | Details | |
| 2/16/2022 | CRISPR Therapeutics | CRSP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 12/14/2021 | Allogene | ALLO | Maintain | Outperform (N/A) |
|
Details | ||
| 12/8/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 11/22/2021 | Alnylam Pharmaceuticals | ALNY | Upgrade | Outperform (Sector Perform) |
178.98 (142.66) |
-20.29% | Details | |
| 11/19/2021 | Dicerna Pharmaceuticals | DRNA | Downgrade | Sector Perform (Outperform) |
21.28 (38.22) |
79.61% | Details | |
| 11/8/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2021 | bluebird bio | BLUE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/11/2021 | Regenxbio Inc. | RGNX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 10/8/2021 | Allogene | ALLO | Maintain | Outperform (N/A) |
|
Details | ||
| 10/7/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 9/14/2021 | Regenxbio Inc. | RGNX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/10/2021 | bluebird bio | BLUE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 8/6/2021 | Dicerna Pharmaceuticals | DRNA | Maintain | Outperform (N/A) |
|
Details | ||
| 7/2/2021 | Arrowhead Pharma | ARWR | Maintain | Outperform (N/A) |
|
Details | ||
| 6/29/2021 | Intellia Therapeutics | NTLA | Maintain | Outperform (N/A) |
|
Details | ||
| 5/4/2021 | Intellia Therapeutics | NTLA | New Coverage | Outperform (N/A) |
76.77 (20.35) |
-73.49% | Details | |
| 5/4/2021 | Beam Inc | BEAM | New Coverage | Sector Perform (N/A) |
82.00 (21.71) |
-73.52% | Details | |
| 5/4/2021 | Editas Medicine | EDIT | New Coverage | Sector Perform (N/A) |
37.01 (5.16) |
-86.06% | Details | |
| 5/4/2021 | Sangamo BioSciences | SGMO | New Coverage | Outperform (N/A) |
11.78 (0.46) |
-96.1% | Details | |
| 4/29/2021 | Adverum Biotechnologies | ADVM | Downgrade | Sector Perform (Outperform) |
10.16 (10.00) |
-1.57% | Details | |
| 4/20/2021 | CRISPR Therapeutics | CRSP | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/30/2021 | WAVE Life Sciences | WVE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/29/2021 | bluebird bio | BLUE | Maintain | Sector Perform (N/A) |
|
Details | ||
| 3/23/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 3/23/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 2/25/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 1/28/2021 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 1/20/2021 | Regenxbio Inc. | RGNX | Maintain | Sector Perform (N/A) |
|
Details | ||
| 11/24/2020 | Arrowhead Pharma | ARWR | Maintain | Outperform (N/A) |
|
Details | ||
| 10/23/2020 | uniQure BV | QURE | New Coverage | Outperform (N/A) |
39.50 (4.42) |
-88.81% | Details | |
| 10/23/2020 | Allogene | ALLO | Maintain | Outperform (N/A) |
|
Details | ||
| 9/1/2020 | Ionis Pharmaceuticals | IONS | Maintain | Outperform (N/A) |
|
Details | ||
| 6/16/2020 | Adverum Biotechnologies | ADVM | Maintain | Outperform (N/A) |
|
Details | ||
| 5/13/2020 | Homology Medicines | FIXX | New Coverage | Outperform (N/A) |
13.49 (0.93) |
-93.11% | Details | |
| 5/13/2020 | Regenxbio Inc. | RGNX | New Coverage | Sector Perform (N/A) |
41.38 (15.75) |
-61.94% | Details | |
| 5/13/2020 | Dicerna Pharmaceuticals | DRNA | New Coverage | Outperform (N/A) |
24.35 (38.22) |
56.96% | Details | |
| 5/13/2020 | Adverum Biotechnologies | ADVM | New Coverage | Outperform (N/A) |
19.80 (10.16) |
-48.69% | Details | |
| 5/13/2020 | bluebird bio | BLUE | New Coverage | Outperform (N/A) |
60.23 (0.91) |
-98.49% | Details | |
| 5/13/2020 | Arrowhead Research | ARWR | New Coverage | Outperform (N/A) |
36.30 (22.73) |
-37.38% | Details | |
| 5/13/2020 | Ionis Pharmaceuticals | IONS | New Coverage | Outperform (N/A) |
56.18 (42.19) |
-24.9% | Details | |
| 5/13/2020 | Alnylam Pharmaceuticals | ALNY | New Coverage | Sector Perform (N/A) |
142.43 (142.66) |
0.16% | Details | |
| 10/23/0003 | CRISPR Therapeutics | CRSP | New Coverage | Sector Perform (N/A) |
92.22 (53.62) |
-41.86% | Details | |
| 10/23/0003 | WAVE Life Sciences | WVE | New Coverage | Sector Perform (N/A) |
8.21 (4.92) |
-40.07% | Details |
